CIC
IDXX icon

Cornercap Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Cornercap Investment Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,933
Closed -$845K – 617
2023
Q3 		$845K Buy
+1,933
New +$964K 0.15% 296

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cornercap Investment Counsel's IDXX Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 1,933 shares — an estimated $845K sold.

Cornercap Investment Counsel first reported a position in IDXX in Q3 2023 and held it in 1 quarter. The position peaked at $845K in Q3 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 1,933 Idexx Laboratories shares in Q4 2023, an estimated $845K.
  • Cornercap Investment Counsel first reported a position in Idexx Laboratories in Q3 2023 and held it in 1 quarter.
  • Cornercap Investment Counsel's Idexx Laboratories position peaked at $845K in Q3 2023.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.